With the help of National Institute of Virology and Indian Council for medical research, Bharath Biotech has been developing a corona vaccine under the name “Covaccine”. Bharath Biotech has tested and identified that there are no side effects. It has released the midterm results of the first phase, after testing on 375 volunteers. Now the clinical trials are in the third phase. Bharath Biotech has already applied for the emergency use in Drug regulatory.

2 thought on “Bharath Biotech says Covaccine is safe”

Leave a Reply

Your email address will not be published.